Market revenue in 2023 | USD 756.7 million |
Market revenue in 2030 | USD 1,102.6 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 77.96% in 2023. Horizon Databook has segmented the Philippines healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The Philippines is becoming a highly attractive pharmaceutical market in Asia Pacific. It is the third-largest pharmaceutical market in Asia Pacific, after Thailand and Indonesia, for CDMO services. Increasing pharmaceutical industry is the major factor responsible for the growth of its CDMO market.
Its pharmaceutical industry is anticipated to grow by 4.5% annually over the next five years and was estimated to reach USD 3.31 million in 2018 from USD 2.9 Million in 2014. Out of the world’s top 20 pharmaceutical companies, more than 14 have manufacturing facilities in the Philippines. Due to these reasons, its CDMO market is expected to grow over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Philippines healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into Philippines healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account